v3.26.1
Income tax expense
6 Months Ended
Dec. 31, 2025
Notes and other explanatory information [abstract]  
Income tax expense

 

8. Income tax expense

 

The major components of income tax expense recognized in profit or loss for the periods ended December 31, 2025 and 2024 were:

 

   July 1, 2025 to   July 1, 2025 to   July 1, 2024 to 
   December 31, 2025   December 31, 2025   December 31, 2024 
   US$   S$   S$ 
             
Current income tax               
- Current year   202,923    260,939    (388)
- Deferred tax credit   (66,144)   (85,055)   - 
Income tax expense recognized in profit or loss   136,779    175,884    (388)

 

Relationship between tax expense and accounting profit

 

A reconciliation between tax expense and the product of accounting profit multiplied by the applicable corporate tax rate for the financial periods ended December 31, 2025 and 2024 were as follows:

 

  

July 1, 2025 to

December 31, 2025

  

July 1, 2025 to

December 31, 2025

  

July 1, 2024 to

December 31, 2024

 
   US$   S$   S$ 
             
Profit/(loss) before tax   261,561    336,342    (90,311)
                
Income tax using the statutory tax rate of 17% -2024: 17%   44,465    57,178    (15,353)
Effects of:               
- Tax effect of items not separately disclosed   92,314    118,706    14,965 
Income tax expense   136,779    175,884    (388)

 

 

Basel Medical Group Ltd and its Subsidiaries

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the financial period ended December 31, 2025